Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Date: 06.08.2026 The Manager Corporate Relations Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street Mumbai – 400001 Dear Sir/Madam, Scrip Code: 524572 | Scrip ID: PHARMAID | ISIN: INE117D01018 Sub: Intimation of Board Meeting under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Pursuant to Regulation 29 of the SEBI Listing Regulations, a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 12, 2026, inter alia, to consider and approve the Unaudited Financial Results (standalone & consolidated) for the quarter ended June 30, 2026. Further, in continuation of our earlier intimation dated June 26, 2026, regarding closure of trading window, we wish to inform you that trading window for dealing in the securities of the Company has been closed from July 01, 2026 and shall re-open after 48 hours from the declaration of the financial results of the Company. This information will also be made available on the Company’s website at www.pharmaids.com Kindly take the same on your record and oblige. For Pharmaids Pharmaceuticals Limited Prasanna Subramanya Bhat (Company Secretary & Compliance Officer) PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979) Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com